Schedules of Controlled Substances: Proposed Placement of Remifentanil Into Schedule II

This proposed rule is issued by the deputy Administrator of the Drug Enforcement Administration (DEA) to place the narcotic drug, remifentanil and salts thereof, into Schedule II of the Controlled Substances Act (CSA). The Deputy Administrator has received a recommendation from the Assistant Secretary for Health of the Department of Health and Human Services (DHHS) that remifentanil, and salts thereof, be added to Schedule II. This rule, if finalized, would require that the manufacture, distribution, dispensing, security, registration, record keeping, inventory, exportation and importation of remifentanil, and salts thereof, be subject to the CSA regulatory control mechanisms and criminal sanctions applicable to Schedule II narcotic substances.